Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.

Int J Oncol 2006 Mar;28(3):641-8

Institute of Neurobiology and Molecular Medicine, CNR, Area Ricerca Roma 'Tor Vergata', I-00133 Rome, Italy.

A number of previous studies investigated the in vitro effects of resveratrol on malignant human breast epithelial cell replication. The aim of the present study was to evaluate the activity of resveratrol on human metastatic breast cancer cells. The study was performed on the MCF-7 tumor cell line. Cell growth, cell cycle perturbation and apoptosis were evaluated by trypan blue dye exclusion assay, flow cytometric analysis and confocal fluorescence microscopy. TRAP assay and Western blot analysis respectively detected levels of telomerase activity and levels of hTERT in intracellular compartments of MCF-7 cells treated with resveratrol. Resveratrol has a direct inhibitory effect on cell proliferation. The results demonstrate that the drug induces apoptosis in MCF-7 cells, in a time- and concentration-related manner. Our results also show that the growth-inhibitory effect of resveratrol on malignant cells is mainly due to its ability to induce S-phase arrest and apoptosis in association with reduced levels of telomerase activity. In particular, TRAP assay and Western blot analysis respectively showed that resveratrol treatment down-regulates the telomerase activity of target cells and the nuclear levels of hTERT, the reverse transcriptase subunit of the telomerase complex. In our experimental model of breast cancer, resveratrol shows direct antiproliferative and pro-apoptotic effects. Studies on telomerase function and intracellular hTERT distribution point out that this agent is endowed with additional suppressive functions on critical tumor biological properties. These results speak in favor of a potential role of resveratrol in chemoprevention/chemotherapy of breast cancer.

Download full-text PDF

Source
March 2006

Publication Analysis

Top Keywords

telomerase activity
16
breast cancer
16
resveratrol
9
assay western
8
resveratrol malignant
8
trap assay
8
blot analysis
8
levels htert
8
mcf-7 cells
8
levels telomerase
8
cancer cells
8
western blot
8
resveratrol direct
8
cells
6
telomerase
6
activity
5
cell
5
breast
5
direct antiproliferative
4
intracellular compartments
4

Similar Publications

EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.

Int J Oncol 2004 Mar;24(3):703-10

Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Telomerase is elevated in >90% of breast carcinomas and therefore has received much attention as a target for breast cancer therapy and cancer diagnostic research. Dietary components that are capable of inhibiting the growth of cancer cells without affecting the growth of normal cells are receiving considerable attention in developing novel cancer-preventive approaches. Studies have shown that (-)-epigallocatechin-3-gallate (EGCG) from green tea imparts a growth inhibitory effect on cancer cells. Read More

View Article and Full-Text PDF
March 2004

siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.

BMC Cancer 2009 May 5;9:133. Epub 2009 May 5.

The Molecular Medicine Center of Shaoxing People's Hospital, The First Affiliate Hospital of Shaoxing University, Shaoxing, PR China.

Background: Doxorubicin is an effective breast cancer drug but is hampered by a severe, dose-dependent toxicity. Concomitant administration of doxorubicin and another cancer drug may be able to sensitize tumor cells to the cytotoxicity of doxorubicin and lowers the therapeutic dosage. In this study, we examined the combined effect of low-dose doxorubicin and siRNA inhibition of telomerase on breast cancer cells. Read More

View Article and Full-Text PDF
May 2009

Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.

J Exp Clin Cancer Res 2006 Jun;25(2):189-93

Institute of Neurobiology and Molecular Medicine, National Research Council, CNR, Area Ricerca Tor Vergata, Rome, Italy.

A number of studies performed in our laboratory and elsewhere, showed that resveratrol is able to prevent carcinogenesis and to impair tumor growth and progression. In order to provide additional information on the pleiotropic effects of resveratrol on malignant cells, the present study was performed to test the in vitro influence of the compound on the growth and TLMA of HT-29 and WiDr human colon cancer cell lines. The results confirmed that resveratrol has a direct, dose dependent, inhibitory effect on cell proliferation in both lines. Read More

View Article and Full-Text PDF
June 2006

Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction.

Oncol Rep 2006 Mar;15(3):637-43

Department of Biology, The Chinese University of Hong Kong, Hong Kong, P.R. China.

Because of the reported immune-enhancing and anti-tumor activities of some mushroom polysaccharides, their applications as biological response modifiers have attracted significant attention. We have purified a water-soluble beta-glucan PCM3-II, comprising mainly 1right curved arrow 3 and 1right curved arrow 4 linkages, from the mycelia of Poria cocos (Schw.) Wolf (Fu-ling). Read More

View Article and Full-Text PDF
March 2006